Inspire Medical Systems (NYSE:INSP) and Sintx Technologies (NASDAQ:SINT) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.
Institutional and Insider Ownership
86.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 0.9% of Sintx Technologies shares are held by institutional investors. 6.6% of Inspire Medical Systems shares are held by insiders. Comparatively, 0.3% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Inspire Medical Systems and Sintx Technologies’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Inspire Medical Systems||$82.05 million||27.52||-$33.24 million||($1.40)||-60.45|
|Sintx Technologies||$690,000.00||32.98||-$4.80 million||N/A||N/A|
Sintx Technologies has lower revenue, but higher earnings than Inspire Medical Systems.
Risk & Volatility
Inspire Medical Systems has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500.
This is a breakdown of current ratings and recommmendations for Inspire Medical Systems and Sintx Technologies, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Inspire Medical Systems||1||1||8||0||2.70|
Inspire Medical Systems presently has a consensus price target of $83.90, suggesting a potential downside of 0.86%. Sintx Technologies has a consensus price target of $2.25, suggesting a potential upside of 19.05%. Given Sintx Technologies’ higher probable upside, analysts clearly believe Sintx Technologies is more favorable than Inspire Medical Systems.
This table compares Inspire Medical Systems and Sintx Technologies’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Inspire Medical Systems||-47.30%||-29.14%||-23.04%|
Inspire Medical Systems beats Sintx Technologies on 7 of the 13 factors compared between the two stocks.
About Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.
About Sintx Technologies
Sintx Technologies, Inc., a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. The company offers ceramic based biomaterial solutions in various medical and industrial applications. It provides spine implant products under the Valeo brand to surgeons and hospitals for use in cervical and thoracolumbar spine surgery. The company markets and sells its products directly; and through direct sales organizations, distributors, as well as original equipment manufacturer and private label partnerships. Sintx Technologies, Inc. has a collaboration agreement with CTL Amedica to design and launch spinal implants. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was founded in 1996 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.